DreamCIS, Inc. (KOSDAQ:223250)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,455.00
+355.00 (11.45%)
At close: Jun 29, 2026

DreamCIS Company Description

DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.

It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services.

The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.

DreamCIS, Inc.
CountrySouth Korea
Founded2000
IndustryCommercial Physical and Biological Research
Employees392
CEOJeongHee Yoo

Contact Details

Address:
Jeokseon-dong, Jeokseon Hyundai Building
Seoul, 110-756
South Korea
Phone82 2 2010 4500
Websitedreamcis.com

Stock Details

Ticker Symbol223250
ExchangeKOSDAQ
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code8731

Key Executives

NamePosition
JeongHee YooChief Executive Officer
Taesik YangChief Financial Officer
GyeongSoon KimChief Operating Officer